classon & grand, LLC

130 lenox ave.
new york, new york 10027

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 07, 2013

NYS DOS ID#
4399991

County
KINGS

Jurisdiction
NEW YORK

Registered Agent
AHKILAH JOHNSON
130 LENOX AVE.
NEW YORK, NEW YORK, 10027

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - CLASSON & GRAND, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Grand Ole Opry, a Nashville Institution, Comes to New York
    By ALAN LIGHT - Tuesday Nov 21, 2017

    The 92-year-old country music show is opening a Southern-themed restaurant and concert space in Times Square, with plans to expand in the U.S. and beyond.

    Source: NYT > Home Page
  • Billionaires, Bruised Egos, and the Death of a Grand Project
    By CHARLES V. BAGLI and ROBIN POGREBIN - Sunday Sep 24, 2017

    Barry Diller was about to win the battle for his $250 million arts pier, but then came the “petty questions” from his opponents and he decided to pull the plug.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed